innovaTV 207: New combination dosing cohorts in the open label phase 2 study of tisotumab vedotin in solid tumors Meeting Abstract


Authors: Le, X.; Carneiro, B. A.; Hong, D. S.; Birnbaum, A. E.; Taylor, M. H.; Patel, S. A.; William, W. N.; Wang, B.; Beca, F.; Jain, S.; Soumaoro, I.; Dunn, L.
Abstract Title: innovaTV 207: New combination dosing cohorts in the open label phase 2 study of tisotumab vedotin in solid tumors
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680305030
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.TPS6100
Notes: Meeting Abstract: TPS6100 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lara   Dunn
    141 Dunn